International Diabetes and Obesity Conference

Overview

img img
texture

Program Overview

img

Target Audience

  • Clinicians
  • Diabetes and Obesity Care Providers
  • Researchers
  • Industries
  • Regulators

Session Format

  • Keynote Talks
  • Four Session Conference
  • Lunch Symposia

Conference Organizer

Al Andalus Events Organizing And Managing L.L.C.

  • +971 554372883, +971 502568985
  • info@andaluseom.com
  • www.alandaluseom.com

Keynotes of IDOC

First Day

Session I
  • Diabesity, the largest epidemic in history?
  • Earlier intervention and expanding treatment options: can oral semaglutide bring the change?
  • How much technology is needed in type 2 diabetes?
  • Falak Tayyeb: a new ecosystem of support for diabetic Patients.
  • A new Era in the management of CKD and the role of Dapagliflozin
Session II
  • Evolving Role of Finerenone in the Management of CKD in T2 D
  • PCSK9 inhibitors a game changer in dyslipidemia management
  • Oral dpp4 inhibitors is hype or hope?
Session III
  • Risk of Diabetes with Statin
  • Automated insulin delivery How to choose the right system?
Session IV
  • Approach to patients with atypical diabetes.
  • Case presentation in pediatric dyslipidemia.
  • Central Precious puberty: revisiting the diagnosis and therapeutic management.
  • A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management.

Second Day

Session I
  • Normo calcemic hyperparathyroidism
  • Checkpoint inhibitors and endocrine diseases
  • Diagnosis and Management of Thyroid nodules
  • Tirze patide approved for weight loss.
  • Diabetes remission utopia or reality ?
Session II
  • The importance of treating beyond LDL-c in Diabetic Patients.
  • Triple protection of Empagliflozin across the cardiorenal metabolic syndromes.
  • Cardiometabolic approach to management of T2D: current evidence for GLP 1-RA in patients with ASCVD.
  • Challenges in Dyslipidemia Management.
  • Time in the range:the missing piece to glucose control.
  • Emerging Therapies for Obesity 2024.
Session III
  • Post-bariatric hypoglycemia
  • Osteoporosis management from a rheumatological point of view
  • Endocrine Grand round
Session IV
  • Diabetes insipidus renaming
  • Obesity and Precision Medicine
Download Agenda